Preliminary probe shows cancer patient received appropriate treatment, says health body


The National Health Commission said on Tuesday that the allegedly expensive and unnecessary treatment provided to a cancer patient from Qinghai is believed to have complied with relevant medical standards and regulations.
Whether the doctor in Shanghai treating the patient had gained illegal benefits by putting the patient through some costly treatment procedures, including NeuroKinetic therapy and genetic testing, was still under investigation, Jiao Yahui, director of the commission's medical supervision and administration bureau, said during a news conference.
In a recent online post, an oncologist from Peking University Third Hospital accused some doctors of malpractice, deliberately choosing substandard or expensive treatment options out of personal interest.
The commission said on April 19 that it had launched an investigation into the allegation.
On Tuesday, Jiao said the commission has required health authorities in Shanghai to further probe into the case involving the patient from Qinghai.
"If illegal exchanges of benefits or propping are found, we will not cover up or turn a blind eye to them. We will handle them severely according to laws and regulations," she said.
- Closed-door seminar highlights China's push for autonomous delivery
- Shanghai district boosts Yangtze Delta integration with 40 new projects
- International award winners among Shanghai audience for World AI Conference
- China proposes global cooperation body on AI
- China shares multi-hazard early warning system globally
- Convention on Wetlands chief praises China's conservation efforts